Lek, a Sandoz company, helps children enjoy their childhood
I have something to tell you!
Since 1954, the first week of October has been dedicated especially to children. In this year’s Children’s Week, between 7 and 11 October, the Slovenian Association of Friends of Youth (SAFY) will underscore the importance of good communication between children, young people and adults. The motto of this year’s campaign is “I have something to tell you”.
The Wink at the Sun initiative, which has been co-created for 17 years now by Lek, a Sandoz company, and SAFY, is certainly contributing to a happy childhood.
This year’s Children’s Week started somewhat differently. The Pogačar Square was hosting SAFY and their associations from Ljubljana in cooperation with the radio station Hitradio Center and the Secondary School for Pharmacy, Cosmetics and Health Care featuring free workshops for children associated with this year’s topic. Deputy Mayor Dejan Crnek and President Borut Pahor held a short speech during the official ceremony.
As noted in the guidelines of this year’s Children’s Week® topic, the communication between children and adults is important and urgent. Communication is always a two-way process in which people perceive and interpret messages they send and receive. However, all too often the communication between children and adults is a one-way process with adults explaining, making orders, commands, warnings, requests, and bans on one hand and children not having the chance to ask or to speak their minds on the other.
Chairman of the Children’s Parliament® Ciril Cerovšek said in his opening speech: “We do not want to argue, fight and live in an environment, where we cannot express ourselves. Instead, children need a safe and loving environment that enables self-discovery. We need an environment for innovative thinking and a good society where children can face their fears and express their thought.
Darja Groznik, SAFY President, urged adults to listen and hear everything children and young people are trying to tell us. Deputy Mayor of the Municipality of Ljubljana Dejan Crnek and President of the Republic of Slovenia Borut Pahor emphasized the importance of organizations such as SAFY, which is making special efforts to spread and recognize the voice of children.
Let the children and young people communicate their needs, wishes, interest, expectations, hopes, fears, anxieties, straits, as well as satisfaction, comfort, happiness and desires without feeling frightened.
About 8,000 children on holidays
SAFY, together with Lek, a Sandoz company, co-creates the Wink at the Sun campaign, which provides free holidays for children from disadvantaged family backgrounds and thereby exercises their right to have a playful and creative childhood. Within the Wink at the Sun campaign, 477 children went on holidays this year. According to information collected so far, a total of more than 8,500 children enjoyed holidays organized by SAFY, of which 2,578 children went on holidays for free. “For children, carefree holidays, packed with new knowledge and experience of making new friends, creating holiday memories is invaluable. They develop habits and values that can grow only in a supportive environment where children and their needs come first. Every child should have this opportunity. Therefore, Lek, a Sandoz company, has been participating with maximum dedication in the Wink at the Sun initiative for 17 years,” said Katarina Klemenc, Head Corporate Communication at Lek, a Sandoz company.
As every year, this year’s Children’s Week® topic is related to the Children’s Parliament® theme The Traps of Youth, which young parliamentarians chose at the 25th National Children’s Parliament® meeting.
A list of events for children across Slovenia organized by various associations during the Children’s Week is available at www.zpms.si.
Lek, a Sandoz company, is one of key pillars of the second-largest generic pharmaceutical company globally. Its role within Sandoz is to act as: a leading global development center for technologically demanding products and technologies; a global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar products; and, a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and Commonwealth of Independent States (CIS), and it is responsible for sales on the Slovenian market. For further information please visit http://www.lek.si/en.
Sandoz, a division of Novartis, is a global leader in generic pharmaceuticals, driving sustainable access to high-quality healthcare. Sandoz employs more than 26,000 people worldwide and supplies a broad range of affordable products to patients and customers around the globe.
The Sandoz global portfolio comprises approximately 1,100 molecules, which accounted for 2014 sales of USD 9.6 billion. Sandoz holds the global #1 position in biosimilars as well as in generic anti-infectives, ophthalmics and transplantation medicines. Sandoz also holds leading global positions in key therapeutic areas ranging from generic injectables, dermatology and respiratory to cardiovascular, metabolism, central nervous system, pain and gastrointestinal.
Sandoz develops, produces and markets finished dosage form (FDF) medicines as well as intermediary products including active pharmaceutical ingredients (APIs) and biotechnological substances. Nearly half of the Sandoz portfolio is in differentiated products – medicines that are scientifically more difficult to develop and manufacture than standard generics.
In addition to strong organic growth since consolidating its generics businesses under the Sandoz brand name in 2003, Sandoz has consistently driven growth in selected geographies and differentiated product areas through a series of targeted acquisitions, including Hexal (Germany), EBEWE Pharma (Austria), and Fougera Pharmaceuticals (US).
Sandoz is on Twitter. Sign up to follow @Sandoz_global at http://twitter.com/Sandoz_Global.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and over-the-counter products. Novartis is the only global company with leading positions in these areas. In 2014, the Group achieved net sales of USD 58.0 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 130,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. For more information, please visit www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
Fax: +386 1 580 24 32